Does SIMVASTATIN Cause Performance status decreased? 35 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Performance status decreased have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.1% of all adverse event reports for SIMVASTATIN.
35
Reports of Performance status decreased with SIMVASTATIN
0.1%
of all SIMVASTATIN reports
1
Deaths
5
Hospitalizations
How Dangerous Is Performance status decreased From SIMVASTATIN?
Of the 35 reports, 1 (2.9%) resulted in death, 5 (14.3%) required hospitalization.
Is Performance status decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Performance status decreased?
BACLOFEN (156)
LENALIDOMIDE (118)
PACLITAXEL (112)
BEVACIZUMAB (103)
SODIUM OXYBATE (103)
CARBOPLATIN (100)
DEXAMETHASONE (80)
CAPECITABINE (75)
NIRAPARIB (75)
LUMATEPERONE (68)
Which SIMVASTATIN Alternatives Have Lower Performance status decreased Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS